1. Home
  2. LOVE vs TNXP Comparison

LOVE vs TNXP Comparison

Compare LOVE & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$14.48

Market Cap

249.4M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$10.82

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
TNXP
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.4M
199.7M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
LOVE
TNXP
Price
$14.48
$10.82
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
283.9K
413.4K
Earning Date
06-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$697,115,000.00
$13,107,000.00
Revenue This Year
$4.63
$558.11
Revenue Next Year
$6.40
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
2.42
29.85
52 Week Low
$10.33
$9.40
52 Week High
$19.25
$25.69

Technical Indicators

Market Signals
Indicator
LOVE
TNXP
Relative Strength Index (RSI) 42.68 33.24
Support Level $12.54 $10.03
Resistance Level $16.47 $12.99
Average True Range (ATR) 0.87 0.55
MACD -0.11 -0.28
Stochastic Oscillator 32.40 10.01

Price Performance

Historical Comparison
LOVE
TNXP

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: